The 5th Joint Meeting on Medicinal Chemistry, organised by the Medicinal Chemistry section of the Slovenian Pharmaceutical Society under the auspices of the European Federation for Medicinal Chemistry (EFMC), was a continuation of the tradition of prior Joint Meetings, the first of which was held in Taormina, Italy in 1999. Subsequent meetings were held in Budapest, Hungary (2001), Krak2w, Poland (2003), and Vienna, Austria (2005). The 5th congress was held in Portoroz ˇ, Slovenia from the 17th to the 21st of June 2007, and was announced as an Austrian–German–Hungarian–Italian– Polish–Slovenian medicinal chemistry meeting, even though it proved to be a worldwide event, attended by over 300 registered participants, most of whom were from Europe, although there were also researchers from Turkey, India, Uruguay, and Japan. The location, with its rich landscape, Mediterranean vegetation, and favourable climate, provided the perfect atmosphere for a stimulating scientific meeting. A lot of fascinating work was presented over the three and a half days of the meeting, covering diverse areas of medicinal chemistry research. These included anti-infectives, drugs for cardiovascular and metabolic disorders, enzymes and receptors as targets for new drugs, computer-aided drug design and discovery, emerging strategies in drug discovery, and medicinal chemistry case studies. The scientific programme was made up of six plenary lectures, 20 keynote lectures, 15 oral presentations, and two poster sessions with about 170 posters in all. The participation of medicinal chemists and other scientists involved in drug discovery and development processes from 26 countries gave this meeting a truly international character. The inaugural plenary lecture on Sunday the 17th was given by the Nobel Laureate, Professor Robert Huber (Max- Planck-InstitAt fAr Biochemie, Martinsried, Germany), who discussed the fundamental role of protein structure information in the understanding of the chemical, physical, and biological properties of proteins, allowing the design and development of specific ligands as useful tools for therapeutic intervention and plant protection.
Highlighting the new advances in drug discovery and development
TALIANI, SABRINA;DA SETTIMO PASSETTI, FEDERICO
2008-01-01
Abstract
The 5th Joint Meeting on Medicinal Chemistry, organised by the Medicinal Chemistry section of the Slovenian Pharmaceutical Society under the auspices of the European Federation for Medicinal Chemistry (EFMC), was a continuation of the tradition of prior Joint Meetings, the first of which was held in Taormina, Italy in 1999. Subsequent meetings were held in Budapest, Hungary (2001), Krak2w, Poland (2003), and Vienna, Austria (2005). The 5th congress was held in Portoroz ˇ, Slovenia from the 17th to the 21st of June 2007, and was announced as an Austrian–German–Hungarian–Italian– Polish–Slovenian medicinal chemistry meeting, even though it proved to be a worldwide event, attended by over 300 registered participants, most of whom were from Europe, although there were also researchers from Turkey, India, Uruguay, and Japan. The location, with its rich landscape, Mediterranean vegetation, and favourable climate, provided the perfect atmosphere for a stimulating scientific meeting. A lot of fascinating work was presented over the three and a half days of the meeting, covering diverse areas of medicinal chemistry research. These included anti-infectives, drugs for cardiovascular and metabolic disorders, enzymes and receptors as targets for new drugs, computer-aided drug design and discovery, emerging strategies in drug discovery, and medicinal chemistry case studies. The scientific programme was made up of six plenary lectures, 20 keynote lectures, 15 oral presentations, and two poster sessions with about 170 posters in all. The participation of medicinal chemists and other scientists involved in drug discovery and development processes from 26 countries gave this meeting a truly international character. The inaugural plenary lecture on Sunday the 17th was given by the Nobel Laureate, Professor Robert Huber (Max- Planck-InstitAt fAr Biochemie, Martinsried, Germany), who discussed the fundamental role of protein structure information in the understanding of the chemical, physical, and biological properties of proteins, allowing the design and development of specific ligands as useful tools for therapeutic intervention and plant protection.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
